Ghent University Academic Bibliography

Your filters: cql: author exact 6A5977EE-052D-11E3-B47B-386110BDE39D

Add to list
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases : results from a randomized trial in ovarian cancer

Jesse Demuytere (UGent) , Charlotte Carlier, Tom Van Helden (UGent) , Joke Belza (UGent) , Frank Vanhaecke (UGent) , Feifan Xie, An Vermeulen (UGent) , Joseph Weerts, Jürgen Thomale, Hannelore Denys (UGent) , et al.

(2024) BRITISH JOURNAL OF SURGERY. 111(4).
Add to list
- Journal Article
- A2
- open access
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma

Arne Claeys (UGent) and Jimmy Van den Eynden (UGent)

(2024) COMMUNICATIONS MEDICINE. 4(1).
Add to list
- PhD Thesis
A computational exploration of MHC-based immune selection signals in large cancer genome sequencing datasets

Arne Claeys (UGent)

(2023)
Add to list
- Journal Article
- A1
- open access
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data

Arne Claeys (UGent) , Peter Merseburger (UGent) , Jasper Staut (UGent) , Kathleen Marchal (UGent) and Jimmy Van den Eynden (UGent)

(2023) BMC GENOMICS. 24.
Add to list
- Journal Article
- A1
- open access
Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Arne Claeys (UGent) and Jimmy Van den Eynden (UGent)

(2023) CANCER RESEARCH. 83(6). p.971-972
Add to list
- Miscellaneous
- open access
Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data

Arne Claeys (UGent) , Jasper Staut (UGent) , Peter Merseburger (UGent) , Kathleen Marchal (UGent) and Jimmy Van den Eynden (UGent)

(2022)
Add to list
- Journal Article
- A1
- open access
A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues

Tom Luijts (UGent) , Kerryn Elliott, Joachim Siaw (UGent) , Joris Van de Velde (UGent) , Elien Beyls (UGent) , Arne Claeys (UGent) , Tim Lammens (UGent) , Erik Larsson, Wouter Willaert (UGent) , Anne Vral (UGent) , et al.

(2022) SCIENTIFIC REPORTS. 12.
Add to list
- Journal Article
- A1
- open access
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Marcus Borenäs, Ganesh Umapathy, Wei‐Yun Lai, Dan E Lind, Barbara Witek, Jikui Guan, Patricia Mendoza‐Garcia, Tafheem Masudi, Arne Claeys (UGent) , Tzu‐Po Chuang, et al.

(2021) EMBO JOURNAL. 40(3).
Add to list
- Journal Article
- A1
- open access
Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signals

Arne Claeys (UGent) , Tom Luijts (UGent) , Kathleen Marchal (UGent) and Jimmy Van den Eynden (UGent)

(2021) PLOS Genetics. 17(2).
Add to list
- Journal Article
- A1
- open access
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models

Joanna Szydzik, Dan E. Lind, Badrul Arefin, Yeshwant Kurhe, Ganesh Umapathy, Joachim Tetteh Siaw, Arne Claeys (UGent) , Jonatan Linus Gabre (UGent) , Jimmy Van den Eynden (UGent) , Bengt Hallberg, et al.

(2021) NATURE COMMUNICATIONS. 12(1).

Academic Bibliography

Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases : results from a randomized trial in ovarian cancer

MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma

A computational exploration of MHC-based immune selection signals in large cancer genome sequencing datasets

Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data

Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Benchmark of tools for in silico prediction of MHC class I and class II genotypes from NGS data

A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signals

ATR inhibition enables complete tumour regression in ALK-driven NB mouse models

Contents

Support

Contact